BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beghetti M, Brand M, Berger RM, Humpl T, Wheeler JG, Ivy DD, Bonnet D. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry. International Journal of Cardiology 2019;289:110-5. [DOI: 10.1016/j.ijcard.2019.04.062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaski JP. Paediatric cardiology - Not just small hearts in small bodies!: An editorial by the section editor of the new section on pediatric cardiology. Int J Cardiol 2022:S0167-5273(22)01027-0. [PMID: 35809808 DOI: 10.1016/j.ijcard.2022.07.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Gorenflo M, Ziesenitz VC. Treatment of pulmonary arterial hypertension in children. Cardiovasc Diagn Ther 2021;11:1144-59. [PMID: 34527540 DOI: 10.21037/cdt-20-912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mukherjee D, Konduri GG. Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment. Compr Physiol 2021;11:2135-90. [PMID: 34190343 DOI: 10.1002/cphy.c200023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ablonczy L, Ferenci T, Somoskövi O, Osváth R, Reusz GS, Kis E. Prognostic Value of Early Risk Stratification in Pediatric Pulmonary Arterial Hypertension. Transplant Proc 2021;53:1439-42. [PMID: 33622612 DOI: 10.1016/j.transproceed.2021.01.047] [Reference Citation Analysis]
5 Migdał A, Żuk M, Jagiełłowicz-Kowalska D, Powichrowska Z, Brzezińska-Rajszys G. Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? Pediatr Cardiol 2020;41:1725-9. [PMID: 32772124 DOI: 10.1007/s00246-020-02434-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chiu SN, Weng KP, Lin MC, Wang JN, Hwang BT, Dai ZK, Lin SM, Chang JS, Lin IC, Wu MH, Lu CW, Lin MT, Chen CA, Hua YC, Wu JM, Wang JK; TACHYON investigators. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry. Int J Cardiol 2020;317:49-55. [PMID: 32522677 DOI: 10.1016/j.ijcard.2020.05.086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Calcaterra G, Bassareo PP, Barilla F, Martino F, Fanos V, Fedele F, Romeo F. Pulmonary hypertension in paediatrics. A feasible approach to bridge the gap between real world and guidelines. J Matern Fetal Neonatal Med 2019;:1-211. [PMID: 31744358 DOI: 10.1080/14767058.2019.1695770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]